LQDA insider trades & Congress trades
Liquidia Corp: public insider filings and Congress disclosures, in one place.
Bourse has recorded 21 open-market insider transactions in Liquidia Corp (LQDA) (0 purchases with code P and 21 sales with code S), the most recent on October 26, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 21 sales by 12 ($25.8M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Adair Jason | Chief Business Officer | Sell | 688 | $43.19 | $30K | – |
| Oct 26, 2026 | Boyle Dana | Chief Accounting Officer | Sell | 1,581 | $43.19 | $68K | – |
| Oct 12, 2026 | Adair Jason | Chief Business Officer | Sell | 7,301 | $28.48 | $208K | – |
| Oct 12, 2026 | Boyle Dana | Chief Accounting Officer | Sell | 5,892 | $28.48 | $168K | – |
| Oct 12, 2026 | Kaseta Michael | CFO and COO | Sell | 18,938 | $28.48 | $539K | – |
| Oct 12, 2026 | Jeffs Roger | Chief Executive Officer | Sell | 32,744 | $28.48 | $933K | – |
| Oct 12, 2026 | Khindri Sanjeev | Chief Development Officer | Sell | 1,101 | $28.48 | $31K | – |
| Oct 12, 2026 | Krepp Sarah | Chief Human Resource Officer | Sell | 5,245 | $28.48 | $149K | – |
| Oct 12, 2026 | Moomaw Scott | Chief Commercial Officer | Sell | 8,863 | $28.48 | $252K | – |
| Oct 12, 2026 | Saggar Rajeev | Chief Medical Officer | Sell | 9,218 | $28.48 | $263K | – |
| Oct 12, 2026 | Schundler Russell | General Counsel | Sell | 13,692 | $28.48 | $390K | – |
| Oct 5, 2026 | Bloch Stephen M | – | Sell | 235,477 | $27.13 | $6.39M | – |
| Sep 14, 2026 | Singh Raman | – | Sell | 8,468 | $66.16 | $560K | −0.5% |
| Sep 11, 2026 | Singh Raman | – | Sell | 9,024 | $68.62 | $619K | −0.5% |
| Sep 1, 2026 | Krepp Sarah | Chief Human Resource Officer | Sell | 274 | $67.76 | $19K | −0.6% |
| Aug 21, 2026 | Adair Jason | Chief Business Officer | Sell | 31,799 | $69.09 | $2.20M | +0.0% |
| Aug 21, 2026 | Adair Jason | Chief Business Officer | Sell | 41,832 | $69.09 | $2.89M | +0.0% |
| Aug 20, 2026 | Rielly-Gauvin Katherine | – | Sell | 18,393 | $72.23 | $1.33M | +0.0% |
| Aug 19, 2026 | Saggar Rajeev | Chief Medical Officer | Sell | 50,000 | $74.06 | $3.70M | −0.1% |
| Aug 19, 2026 | Rielly-Gauvin Katherine | – | Sell | 36,789 | $74.99 | $2.76M | +0.0% |
| Aug 17, 2026 | Saggar Rajeev | Chief Medical Officer | Sell | 29,534 | $76.84 | $2.27M | −0.1% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.